Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials
Authors:
- 24 October 2023
- journal article
- research article
- Published by Massachusetts Medical Society in NEJM Evidence
- Vol. 2 (11)
Abstract
Win Statistics in HF TrialsIn this study, we applied win statistics to the DAPA-HF and DELIVER trials, exploring the effect of dapagliflozin on a composite outcome incorporating patient-reported outcomes as well as total heart failure events and cardiovascular deaths.Keywords
This publication has 40 references indexed in Scilit:
- An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoringStatistical Methods in Medical Research, 2016
- On the win-ratio statistic in clinical trials with multiple types of eventBiometrika, 2016
- Large sample inference for a win ratio analysis of a composite outcome based on prioritized componentsBiostatistics, 2015
- Application of the Wei–Lachin multivariate one-directional test to multiple event-time outcomesClinical Trials, 2015
- An Alternative Approach to Confidence Interval Estimation for the Win Ratio StatisticBiometrics, 2014
- Opportunities and challenges of combined effect measures based on prioritized outcomesStatistics in Medicine, 2013
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical prioritiesEuropean Heart Journal, 2011
- Generalized pairwise comparisons of prioritized outcomes in the two‐sample problemStatistics in Medicine, 2010
- Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trialsBMJ, 2007
- Semiparametric Regression for the Mean and Rate Functions of Recurrent EventsJournal of the Royal Statistical Society Series B: Statistical Methodology, 2000